Histological, Genetic and Epigenetic Analysis of Procedures Related with Dental Implants
NCT ID: NCT04421066
Last Updated: 2025-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2019-01-29
2022-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysising the Marginal Bone Loss, Torque and Implant Stability Placed in Bone and Tissue Level Dental Implants
NCT07288606
Impact of Genetic Polymorphisms on Dental Implant Loss
NCT01274442
Early and Late Implant Failure
NCT04270396
Study to Evaluate Bone and Gum Dimension Changes Around Dental Implants Placed in Different Positions in Bone.
NCT01759537
Short Implants Supporting Single Crowns in the Posterior Region
NCT05081050
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Nucleic acid extraction and histological analysis of the samples will be performed to evaluate the functional epigenetic modifications associated with peri-implant diseases, in an exploratory manner.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peri-implantitis
Patients with at least one dental implant diagnosed with peri-implantitis undergoing treatment for peri-implantitis as their standard of care will be included in this study.
Gingival and bone sample collection
Gingival and bone samples will be collected from the sites affected by peri-implantitis during their surgical treatment of peri-implantitis or histological and epigenetic analysis.
Healthy
Patients with general good health and health gingiva undergoing extraction of wisdom tooth will be included in this study group.
Healthy individuals
Gingival and bone samples will be collected from the extraction sites for histological and epigenetic analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gingival and bone sample collection
Gingival and bone samples will be collected from the sites affected by peri-implantitis during their surgical treatment of peri-implantitis or histological and epigenetic analysis.
Healthy individuals
Gingival and bone samples will be collected from the extraction sites for histological and epigenetic analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subjects must be between 20-90 years of age.
* Subjects must be non-smokers or former smokers who have quit smoking for at least one year prior to enrollment in the study.
In addition to the general criteria listed, samples of a healthy periodontal subject must meet the following criteria when reviewing their medical and dental history :
-Subjects do not have or have had a history of periodontal disease, as described in the " 2017 World Workshop on the Classification of Periodontal and Peri- Implant Diseases and Conditions "
Samples from a subject with peri-implant disease must meet the following criteria:
-Samples of subjects who have at least one implant - supported prosthesis for at least 12 months and affected by peri- implant disease according to the " 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions "
Exclusion Criteria
* Samples of subjects who were taking antibiotics within 1 month before collection of the sample.
* Samples of subjects with chronic use of non-steroidal anti-inflammatory drugs for more than 3 weeks at the time of sample collection. The use of aspirin in low doses (≤81 mg / day) will be allowed .
* Samples from subjects with disease in the mucosa in the area located around the site of sample collection.
* Samples of subjects with a systemic disease that would exclude the analysis (for example, severe medical problems, bone metabolism disorders, uncontrolled bleeding disorders, depressed immune system, diseases that require the periodic use of steroids, uncontrolled endocrine disorders) .
* Samples of subjects with a history of local irradiation therapy in the head / neck area.
* Samples of subjects with a history of having received treatment with intravenous or subcutaneous antiresorptive agents associated with osteonecrosis of the jaw, such as bisphosphonates.
Samples of subjects assigned to the healthy group that meet any of the following criteria will be excluded from participation in this study:
* Root fragments, pericoronaritis, endo-perio lesions, dental abscesses at the site of the biopsy.
* Presence of BOP in the sample collection site.
Peri- implant disease samples / Exclusion of Subjects
The samples of the subjects assigned to the peri- implant diseases group that meet any of the following criteria will be excluded from participation in this study if the implants were removed due to:
* Inadequate position of the implant.
* Subjects with implants previously treated surgically for peri- implant disease with antibiotics.
20 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Göteborg University
OTHER
University Hospital A Coruña
OTHER
Instituto de Investigacion Biomedica de A Coruna
OTHER
Simón Pardiñas López
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simón Pardiñas López
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simón Pardiñas López, DDS, MS
Role: PRINCIPAL_INVESTIGATOR
Fundación Clínica Pardiñas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundacion Clinica Pardiñas
A Coruña, Galicia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-101718
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.